Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Somatostatin Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT03197012
What this trial is testing

Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

Who this might be right for
Neuroendocrine Tumor
Thomas Hope 10
Testing effectiveness (Phase 2)UnknownNCT04491851
What this trial is testing

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01967537
What this trial is testing

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsVon Hippel-Lindau SyndromeHippel-Lindau Disease
National Cancer Institute (NCI) 341
Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Large-scale testing (Phase 3)Study completedNCT00495846
What this trial is testing

GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Federico II University 25
Testing effectiveness (Phase 2)Looking for participantsNCT06456359
What this trial is testing

Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell TumorSynovial Sarcoma
University Hospital Heidelberg 28
Testing effectiveness (Phase 2)Ended earlyNCT02489604
What this trial is testing

Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 70
Testing effectiveness (Phase 2)Looking for participantsNCT06427798
What this trial is testing

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Who this might be right for
Somatostatin Receptor PositiveGastrointestinal Neuroendocrine TumorsPheochromocytoma+1 more
National Cancer Institute (NCI) 66
Large-scale testing (Phase 3)Study completedNCT01620138
What this trial is testing

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Who this might be right for
Non-functioning Pituitary AdenomasProlactinomas
Universidade Federal do Rio de Janeiro 21
Testing effectiveness (Phase 2)Study completedNCT03548415
What this trial is testing

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Who this might be right for
Acromegaly
Ionis Pharmaceuticals, Inc. 43
Very early researchUnknownNCT05359146
What this trial is testing

Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)

Who this might be right for
Neuroendocrine Neoplasia's (NENs)Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
University Hospital, Basel, Switzerland 16
Testing effectiveness (Phase 2)Study completedNCT00006370
What this trial is testing

Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer

Who this might be right for
Breast CancerLung Cancer
Novartis Pharmaceuticals 275
Early research (Phase 1)Active Not RecruitingNCT05595460
What this trial is testing

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

Who this might be right for
SCLC,Extensive Stage
RayzeBio, Inc. 21
Not applicableStudy completedNCT05581550
What this trial is testing

Somatostatin Receptor Imaging in NPC, EBV Related Cancers

Who this might be right for
Nasopharyngeal CancerEpstein-Barr Virus Related Carcinoma
National Cancer Centre, Singapore 15
Not applicableStudy completedNCT03746847
What this trial is testing

PET Imaging in Patients With Suspected Cardiac Sarcoidosis

Who this might be right for
Cardiac Sarcoidosis
University of Pennsylvania 20
Early research (Phase 1)Study completedNCT03883776
What this trial is testing

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven 12
Not applicableStudy completedNCT02021188
What this trial is testing

Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography

Who this might be right for
AtherosclerosisStrokeTransient Ischemic Attack+2 more
University of Cambridge 42
Testing effectiveness (Phase 2)Looking for participantsNCT04997317
What this trial is testing

Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Who this might be right for
Meningioma
University Hospital, Basel, Switzerland 18
Testing effectiveness (Phase 2)UnknownNCT05880394
What this trial is testing

Study of Dotatate Imaging in Breast Cancer

Who this might be right for
Breast Cancer Stage IV
Hoag Memorial Hospital Presbyterian 30
Not applicableStudy completedNCT04727723
What this trial is testing

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Novartis Pharmaceuticals 164
Next Page